https://pharmadog.xyz/news/544019 pharmadog en 2026-10-15T10:33:24.000Z Former Galapagos CEO Paul Stoffels aims to revive cell therapy projects at new biotech Armed Cell https://pharmadog.xyz/news/544063 pharmadog en 2026-10-15T10:30:00.000Z Biotech investors grow uneasy as XBI stalls despite overall gains https://pharmadog.xyz/news/544043 pharmadog en 2026-10-15T10:26:01.000Z Cytiva podcast highlights decision confidence as key bottleneck in biopharma development https://pharmadog.xyz/news/543619 pharmadog en 2026-10-15T08:30:00.000Z Around 40% of U.S. high schoolers report binge‑eating in past month, new CDC data shows https://pharmadog.xyz/news/543620 pharmadog en 2026-10-15T08:30:00.000Z Patients struggle to opt out of MyChart data sharing, facing notary and endless hurdles https://pharmadog.xyz/news/543621 pharmadog en 2026-10-15T08:30:00.000Z Personal tragedy highlights deeper flaws in nursing workforce and training gaps https://pharmadog.xyz/news/543575 pharmadog en 2026-10-15T08:01:53.000Z Nvidia-backed Iambic Therapeutics raises $150M in IPO, begins trading Thursday https://pharmadog.xyz/news/543239 pharmadog en 2026-10-15T06:00:59.000Z Oxford biotech OMass Therapeutics secures $310 million to advance genetic adrenal disorder program https://pharmadog.xyz/news/543550 pharmadog en 2026-10-15T04:11:00.000Z Lakefront Biotherapeutics sells its cell therapy pipeline to Belgian biotech Armed Cell Therapeutics https://pharmadog.xyz/news/543994 pharmadog en 2026-10-15T03:36:00.000Z AstraZeneca signs $1.5B AI partnership with insitro to discover liver and heart disease targets https://pharmadog.xyz/news/543214 pharmadog en 2026-10-15T02:31:00.000Z Iambic Therapeutics raises $150 million in IPO to fund oncology drug development https://pharmadog.xyz/news/543215 pharmadog en 2026-10-15T02:26:00.000Z Vanda pauses social anxiety program after ex-Novartis asset flunks phase 3 study https://pharmadog.xyz/news/542187 pharmadog en 2026-10-15T00:08:00.000Z Iambic Therapeutics raises $150 million in IPO, begins Nasdaq trading under ticker IAM https://pharmadog.xyz/news/542167 pharmadog en 2026-10-15T00:01:24.000Z Compass Pathways CEO says company will proceed cautiously as it readies psychedelic therapy for FDA review https://pharmadog.xyz/news/541891 pharmadog en 2026-10-14T23:23:20.000Z Former FDA leaders denounce agency layoffs as historic disaster https://pharmadog.xyz/news/541723 pharmadog en 2026-10-14T22:13:33.000Z MIT reports 20% drop in graduate enrollment after $100 million federal research cut, warning of basic-research drought https://pharmadog.xyz/news/541279 pharmadog en 2026-10-14T20:16:59.000Z Trump administration delays rule that could curb imported prescription drugs https://pharmadog.xyz/news/541067 pharmadog en 2026-10-14T19:06:14.000Z Sanofi R&D chief urges Western pharma to factor China’s growing innovation into pipelines https://pharmadog.xyz/news/540899 pharmadog en 2026-10-14T18:20:47.000Z FDA proposes new framework prioritizing consistency over flexibility for rare disease drug reviews https://pharmadog.xyz/news/540943 pharmadog en 2026-10-14T18:16:08.000Z Whoop joins Medicare ACCESS program to offer free wearables and support to seniors https://pharmadog.xyz/news/540519 pharmadog en 2026-10-14T15:54:00.000Z Arrowhead’s experimental RNAi drug ARO-MAPT cuts tau protein by 73% in early human trial https://pharmadog.xyz/news/540287 pharmadog en 2026-10-14T15:52:24.000Z Verastem makes its stand as a RevMed competitor in pancreatic cancer https://pharmadog.xyz/news/540814 pharmadog en 2026-10-14T15:50:52.000Z FDA launches Rare Disease Framework Initiative to reshape drug development for small patient populations https://pharmadog.xyz/news/540370 pharmadog en 2026-10-14T15:14:51.000Z FDA expands Anktiva use for BCG-unresponsive high-grade papillary bladder cancer https://pharmadog.xyz/news/540311 pharmadog en 2026-10-14T15:01:01.000Z Gilead invests up to $1.87 B in Vir Biotechnology for three T-cell engagers https://pharmadog.xyz/news/540312 pharmadog en 2026-10-14T15:00:50.000Z Verastem reports robust response in pancreatic cancer subgroup where Revolution's drug lagged https://pharmadog.xyz/news/540351 pharmadog en 2026-10-14T15:00:00.000Z Verastem’s experimental KRAS drug shows early promise in small study, shares jump 18% https://pharmadog.xyz/news/541133 pharmadog en 2026-10-14T14:45:52.000Z CVS agrees to $315 million settlement over alleged improper opioid prescriptions https://pharmadog.xyz/news/540143 pharmadog en 2026-10-14T14:41:10.000Z FTC seeks contempt ruling against Martin Shkreli for breaching lifetime pharma ban https://pharmadog.xyz/news/540144 pharmadog en 2026-10-14T14:24:44.000Z GSK to cut over 1,200 jobs at Belgian sites as $2.5 bn restructuring continues https://pharmadog.xyz/news/540119 pharmadog en 2026-10-14T14:24:20.000Z Ultragenyx sells second priority review voucher as Biomea shares tumble after oral GLP-1 data https://pharmadog.xyz/news/540163 pharmadog en 2026-10-14T14:12:14.000Z Study finds almost 40% of FDA advisory committee meetings in past two decades included members with active industry ties https://pharmadog.xyz/news/540352 pharmadog en 2026-10-14T13:31:00.000Z Johnson & Johnson shares drop 6% after earnings meet forecasts but show weak medical device outlook https://pharmadog.xyz/news/539995 pharmadog en 2026-10-14T13:26:39.000Z FTC and states seek contempt order against Martin Shkreli for breaching pharma work ban https://pharmadog.xyz/news/539996 pharmadog en 2026-10-14T13:17:57.000Z Radical Numerics aims to develop general biological intelligence, says CEO Eric Nguyen https://pharmadog.xyz/news/539975 pharmadog en 2026-10-14T13:11:53.000Z Zealand Pharma to invest up to $1.2 billion in Generate’s AI platform for obesity drug development https://pharmadog.xyz/news/539783 pharmadog en 2026-10-14T12:30:21.000Z Vir Biotechnology signs $65M upfront deal with Gilead for solid tumor T-cell engager https://pharmadog.xyz/news/539719 pharmadog en 2026-10-14T12:17:35.000Z Sanofi avoids fine as EU ends antitrust probe over alleged disparagement of rival flu vaccine https://pharmadog.xyz/news/539551 pharmadog en 2026-10-14T11:53:49.000Z Study explores how GLP-1 weight-loss drugs affect criminal justice involvement, job prospects and housing stability https://pharmadog.xyz/news/123087 pharmadog en 2026-10-14T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/539507 pharmadog en 2026-10-14T11:30:27.000Z Arrowhead’s RNA drug cuts Alzheimer’s tau protein in early human study https://pharmadog.xyz/news/538247 pharmadog en 2026-10-14T11:22:31.000Z Alnylam shares tumble to $250 after cutting full-year revenue guidance for its TTR franchise https://pharmadog.xyz/news/539508 pharmadog en 2026-10-14T11:21:47.000Z Zealand Pharma signs up to $1.3 billion AI partnership with Generate Biomedicines for protein-based obesity drugs https://pharmadog.xyz/news/539339 pharmadog en 2026-10-14T10:41:26.000Z GSK to cut up to 1,200 jobs in Belgium as part of cost-cutting plan https://pharmadog.xyz/news/540262 pharmadog en 2026-10-14T10:32:00.000Z Verastem reports promising early results for KRAS G12D inhibitor in pancreatic and lung cancers https://pharmadog.xyz/news/540094 pharmadog en 2026-10-14T10:13:00.000Z Verdiva Bio halts phase 2 oral GLP-1 trial after enrolling only eight participants https://pharmadog.xyz/news/539195 pharmadog en 2026-10-14T09:44:02.000Z J&J Q3 earnings fall short of expectations as stock slides, BMS reports mixed trial outcomes and RevMed highlights subgroup data https://pharmadog.xyz/news/540095 pharmadog en 2026-10-14T09:24:00.000Z Biomea posts modest Phase 1 results for oral GLP-1 drug, shares slide https://pharmadog.xyz/news/539047 pharmadog en 2026-10-14T08:30:00.000Z Doctors, hospitals and insurers lobby states on medical AI regulation https://pharmadog.xyz/news/539048 pharmadog en 2026-10-14T08:30:00.000Z States could counter potential Trump administration vaccine shortages by producing vaccines themselves https://pharmadog.xyz/news/539049 pharmadog en 2026-10-14T08:30:00.000Z Early-life gut microbiome may influence lifelong brain health, experts say https://pharmadog.xyz/news/543216 pharmadog en 2026-10-14T07:51:00.000Z OMass Therapeutics secures $310M Series C, eyes status as Britain’s leading biotech https://pharmadog.xyz/news/539314 pharmadog en 2026-10-14T06:39:00.000Z GSK to cut up to 1,217 jobs in Belgium as cost-saving plan accelerates https://pharmadog.xyz/news/538248 pharmadog en 2026-10-14T04:30:00.000Z European biotech CEOs divided on whether US or China will lead future partnership deals, Europe seen as lagging https://pharmadog.xyz/news/538978 pharmadog en 2026-10-14T04:09:00.000Z Zealand Pharma partners with Generate Biomedicines on multispecific obesity proteins in $1.2B deal https://pharmadog.xyz/news/538249 pharmadog en 2026-10-14T04:01:00.000Z Jazz CEO urges industry to boost gender diversity in biopharma leadership https://pharmadog.xyz/news/500951 pharmadog en 2026-10-14T04:00:00.000Z BD and CareFusion recall Alaris Pump infusion sets due to serious performance risks https://pharmadog.xyz/news/538810 pharmadog en 2026-10-14T03:36:00.000Z Agilent to acquire digital pathology software firm Proscia for $240 million upfront https://pharmadog.xyz/news/541753 pharmadog en 2026-10-14T00:00:00.000Z UK regulator MHRA unveils multi-year plan to speed AI-driven drug oversight https://pharmadog.xyz/news/536895 pharmadog en 2026-10-13T21:00:00.000Z Connectivity in fluid management systems key to reducing process variability https://pharmadog.xyz/news/536727 pharmadog en 2026-10-13T20:35:00.000Z Paragon spinout Velaris Therapeutics goes public via reverse merger with Alaunos, raising $350 million https://pharmadog.xyz/news/536707 pharmadog en 2026-10-13T20:25:40.000Z BlackRock to acquire majority stake in Humana’s CenterWell clinics for $2.8 billion https://pharmadog.xyz/news/539758 pharmadog en 2026-10-13T20:14:00.000Z Gilead signs $1.9 billion deal with Vir Biotechnology to license dual-masked T-cell engagers for oncology https://pharmadog.xyz/news/536495 pharmadog en 2026-10-13T19:04:39.000Z FTC and seven states seek contempt order against Martin Shkreli for breaching lifetime pharma ban https://pharmadog.xyz/news/536327 pharmadog en 2026-10-13T18:51:04.000Z Novartis secures supplemental FDA approval to market repurposed antibiotic Lamprene in the US https://pharmadog.xyz/news/536371 pharmadog en 2026-10-13T18:11:36.000Z Veteran infectious disease journalist Helen Branswell dies at 69 https://pharmadog.xyz/news/541022 pharmadog en 2026-10-13T18:07:00.000Z Pan Pepin recalls Para Bien Al Grano boxes after discovering undeclared sesame https://pharmadog.xyz/news/536095 pharmadog en 2026-10-13T18:00:13.000Z Study finds nearly 40% of FDA advisory panels include reps linked to pharma-funded advocacy groups https://pharmadog.xyz/news/541023 pharmadog en 2026-10-13T18:00:00.000Z Pan Pepín recalls Para Bien Al Grano cereal batches over undeclared sesame allergen https://pharmadog.xyz/news/536051 pharmadog en 2026-10-13T17:42:27.000Z Verdiva Bio halts mid-stage obesity trial of its GLP-1 pill, citing market evolution https://pharmadog.xyz/news/535883 pharmadog en 2026-10-13T16:54:10.000Z Soufflé Therapeutics raises $135 million to develop three RNA medicines https://pharmadog.xyz/news/535947 pharmadog en 2026-10-13T16:24:00.000Z BioNTech's mRNA cancer therapy fails to improve progression-free survival in head-neck cancer trial https://pharmadog.xyz/news/535927 pharmadog en 2026-10-13T16:07:06.000Z North Carolina public worker health plan faces court challenge over provider restrictions https://pharmadog.xyz/news/535779 pharmadog en 2026-10-13T15:49:00.000Z Roche signs $1 billion deal with China’s Rona Therapeutics for RNAi obesity drug https://pharmadog.xyz/news/535759 pharmadog en 2026-10-13T15:43:56.000Z Doctors donate heavily to fellow physicians running for office amid Medicare overhaul debate https://pharmadog.xyz/news/535715 pharmadog en 2026-10-13T15:37:36.000Z Beam Therapeutics reports early Phase 1/2 data for base editing therapy in GSD Ia, partners with Pfizer and Enodia https://pharmadog.xyz/news/535739 pharmadog en 2026-10-13T15:20:01.000Z J&J’s innovative medicines carried Q3 as medtech disappoints, but newer medicines absent https://pharmadog.xyz/news/540706 pharmadog en 2026-10-13T15:17:00.000Z iOnctura’s roginolisib shows encouraging phase 1 results in metastatic uveal melanoma https://pharmadog.xyz/news/535740 pharmadog en 2026-10-13T15:00:29.000Z BioNTech's head and neck cancer mRNA vaccine fails to extend progression-free survival in Phase 3 trial https://pharmadog.xyz/news/535547 pharmadog en 2026-10-13T15:00:01.000Z Rudy Tanzi says he may be nearing a cheap, safe Alzheimer’s prevention pill https://pharmadog.xyz/news/535548 pharmadog en 2026-10-13T14:59:28.000Z BioNTech's head and neck cancer vaccine fails to meet first primary endpoint in pivotal trial https://pharmadog.xyz/news/535549 pharmadog en 2026-10-13T14:56:16.000Z Health tech firms expand AI scribing tools toward prescribing and billing functions https://pharmadog.xyz/news/540391 pharmadog en 2026-10-13T14:52:00.000Z Par Health initiates voluntary recall of Argatroban injection after detecting particulate contaminants https://pharmadog.xyz/news/535591 pharmadog en 2026-10-13T14:31:08.000Z FTC and seven states seek contempt order against Martin Shkreli for breaching pharma work ban https://pharmadog.xyz/news/535571 pharmadog en 2026-10-13T14:27:21.000Z Roche expands obesity R&D footprint with Rona deal worth $1B+ https://pharmadog.xyz/news/539762 pharmadog en 2026-10-13T13:53:00.000Z Stryker invests $400 million in CMR Surgical, securing exclusive U.S. rights to Versius robotic platform https://pharmadog.xyz/news/540874 pharmadog en 2026-10-13T13:44:00.000Z IQVIA and Veeva deepen partnership to accelerate clinical trial timelines https://pharmadog.xyz/news/535423 pharmadog en 2026-10-13T13:29:22.000Z Patient advocates and experts raise alarm over safety of Neurocrine Biosciences rare disease drug https://pharmadog.xyz/news/535424 pharmadog en 2026-10-13T13:13:25.000Z Lancet study assesses performance of Google’s diagnostic chatbot AMIE https://pharmadog.xyz/news/535379 pharmadog en 2026-10-13T13:00:59.000Z Readily secures $11 million to expand AI compliance platform for insurers https://pharmadog.xyz/news/535235 pharmadog en 2026-10-13T12:55:29.000Z Syndax halts Niktimvo trial for idiopathic pulmonary fibrosis after mid-stage failure https://pharmadog.xyz/news/535236 pharmadog en 2026-10-13T12:09:59.000Z Pfizer strikes over $500M partnership with Enodia to develop Sec61-targeting small-molecule drugs